https://medicaldialogues.in/news/industry/pharma/intranasal-covid-vaccine-bharat-biotech-seeks-dcgi-nod-for-phase-3-study-of-incovacc-in-5-18-age-group-98989
Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group